Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily, have signed a consent form, and are expected to follow the study requirements
- People aged 18 to 80 years old at the time of signing the consent form, with a general health and activity level rated 0–2 on a standard oncology scale (meaning able to carry out at least some daily activities) (confirm with trial site)
- People who have been diagnosed with diffuse large B-cell lymphoma (a type of blood cancer) confirmed by a tissue sample, who have measurable signs of disease, and whose cancer did not go into full remission or came back after at least two previous treatments
- Women of childbearing age who agree to use contraception (such as an IUD, birth control pills, or condoms) throughout the study and for six months after it ends, have had a negative pregnancy blood test within 7 days before joining, and are not breastfeeding; male participants who agree to use contraception during the study and for six months after it ends
Who may not be able to join:
- People whose lymphoma is specifically located in the brain or spinal cord (primary central nervous system DLBCL), or whose lymphoma is of a type that starts in the chest area called primary mediastinal large B-cell lymphoma
- People with serious or poorly controlled health conditions, including heart failure with symptoms, uncontrolled high blood pressure, unstable chest pain (angina), active stomach ulcers, or serious bleeding disorders such as haemophilia A, haemophilia B, von Willebrand disease, or a history of spontaneous bleeding that needed a transfusion or other medical treatment
- People with a history of an active immune or autoimmune disease, or who have previously received a donated organ transplant or donated stem cell transplant
- People who have had an active infection requiring antibiotics, antifungals, or antiviral medicines within the 14 days before starting the study treatment
- People who are currently taking part in another clinical trial, or who finished a previous clinical trial's treatment less than 4 weeks ago
- People who, in the treating doctor's judgment, have other health conditions that could put them at serious risk or interfere with completing the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haiyan Yang, PhD, Zhejiang Cancer Hospital
Phone: 15157155533
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.